Certified Registered Nurse Anesthetist (CRNA) Practice Exam 2026 – All-in-One Resource for Exam Success!

Respiratory depression is a well-documented side effect of opioids used in anesthesia. Opioids provide analgesia by binding to specific receptors in the brain and spinal cord, which not only helps alleviate pain but can also depress the central nervous system's capability to regulate breathing. This is particularly important to recognize in the perioperative setting, as the combination of opioids with other anesthetic agents can further enhance this effect, leading to inadequate ventilation and potential respiratory failure.

While nausea, hypotension, and delayed recovery can occur with opioid use, respiratory depression stands out due to its immediate and potentially life-threatening implications. It requires careful monitoring and may necessitate interventions such as supplemental oxygen or antagonistic agents like naloxone to reverse the effects if respiratory distress occurs. Understanding this side effect is critical for CRNAs, as they must be prepared to manage the airway and ensure the patient maintains adequate respiratory function during and after anesthesia.